Metabolic perturbations sensitize triple-negative breast cancers to apoptosis induced by BH3 mimetics
Authors:
- Veerle W. DanielsVDVeerle W. Daniels
- Jason J. ZoellerJZJason J. Zoeller
- Nick van GastelNGNick van Gastel
- Kelley E. McQueeneyKMKelley E. McQueeney
- Salma ParvinSPSalma Parvin
- Geoffrey G. FellGFGeoffrey G. Fell
- Vinícius G. FerreiraVFVinícius G. Ferreira
- Johan SpetzJSJohan Spetz
- Patrick D. BholaPBPatrick D. Bhola
- 8 June 2021
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 14 (686)
Abstract
Cancer cells have differential metabolic dependencies compared to their nonmalignant counterparts. However, few metabolism-targeting compounds have been successful in clinical trials. Here, we investigated the metabolic vulnerabilities of triple-negative breast cancer (TNBC), particularly those metabolic perturbations that increased mitochondrial apoptotic priming and sensitivity to BH3 mimetics (drugs that antagonize antiapoptotic proteins). We used high-throughput dynamic BH3 profiling (HT-DBP) to screen a library of metabolism-perturbing small molecules, which revealed inhibitors of the enzyme nicotinamide phosphoribosyltransferase (NAMPT) as top candidates. In some TNBC cells but not in nonmalignant cells, NAMPT inhibitors increased overall apoptotic priming and induced dependencies on specific antiapoptotic BCL-2 family members. Treatment of TNBC cells with NAMPT inhibitors sensitized them to subsequent treatment with BH3 mimetics. The combination of a NAMPT inhibitor (FK866) and an MCL-1 antagonist (S63845) reduced tumor growth in a TNBC patient–derived xenograft model in vivo. We found that NAMPT inhibition reduced NAD+ concentrations below a critical threshold that resulted in depletion of adenine, which was the metabolic trigger that primed TNBC cells for apoptosis. These findings demonstrate a close interaction between metabolic and mitochondrial apoptotic signaling pathways and reveal that exploitation of a tumor-specific metabolic vulnerability can sensitize some TNBC to BH3 mimetics.Keywords
Funding Information
- Alex’s Lemonade Stand Foundation for Childhood Cancer
- Alex’s Lemonade Stand Foundation for Childhood Cancer
- Terri Brodeur Breast Cancer Foundation
- Ludwig Center at Harvard (R35 CA242427)
- Ludwig Center at Harvard (03/01/15-09/30/19)
- Ludwig Center at Harvard (01/01/2019-12/31/2020)
- Ludwig Center at Harvard (202424/2017-0)
- Ludwig Center at Harvard (20-20-26-HARR)
- Ludwig Center at Harvard (NIH/NCI R00-CA188679)
- Ludwig Center at Harvard
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (R35 CA242427)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (03/01/15-09/30/19)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (01/01/2019-12/31/2020)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (202424/2017-0)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (NIH/NCI R00-CA188679)
- funding
- CNPq, National Council for Scientific and Technological Development – Brazil (202424/2017-0)
- Tap Cancer Out
- Ludwig Center at Harvard
- NIH/NCI (R35 CA242427)
- NIH/NCI (R00-CA188679)
This publication has 61 references indexed in Scilit:
- Targeting cellular metabolism to improve cancer therapeuticsCell Death & Disease, 2013
- Synthetic lethality of PARP and NAMPT inhibition in triple‐negative breast cancer cellsEMBO Molecular Medicine, 2012
- Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic ChemotherapyScience, 2011
- Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomesNature Medicine, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Catastrophic NAD+ Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAEPLOS ONE, 2009
- Control of mitochondrial apoptosis by the Bcl-2 familyJournal of Cell Science, 2009
- BCL-2 dependence and ABT-737 sensitivity in acute lymphoblastic leukemiaBlood, 2008
- HMDB: the Human Metabolome DatabaseNucleic Acids Research, 2007
- KEGG: Kyoto Encyclopedia of Genes and GenomesNucleic Acids Research, 2000